Board of Directors

Board of Directors

PathoQuest’s management team has significant experience and expertise with in vitro diagnostics and the development, validation and commercialization of metagenomic solutions for the identification of pathogens.

Benedikt von Braunmühl – Chairman

Benedikt von Braunmühl – Chairman

Mr. Von Braunmühl serves as CEO of the Synevo Division at Medicover. Mr. Von Braunmühl has held several high-profile healthcare consulting and advisory roles for companies across the globe supporting geographic expansion, business development, and mergers and acquisitions projects. Mr. Von Braunmühl previously was Senior Vice President – Global Commercial Operations of Qiagen NV. Mr. Von Braunmühl started his 25-year healthcare career at AstaMedica and has held various marketing and sales positions in the healthcare industry as well as in investment banking. Mr. Von Braunmühl holds a Bachelor Degree in Business Administration from the Graduate School of Business Administration in Zurich, Switzerland. →

Christiane Honisch, PhD

Christiane Honisch, PhD

Dr. Honisch is currently Head of Global Business Intelligence and Development at Eppendorf AG. She was formerly the Director of Microbiology Markets at Illumina, Inc. Prior to this, she was the Director of Infectious Disease Research at Roche Molecular Diagnostics. Her team received the Roche Innovation Award in 2014. Previously she was key in the commercial use of nucleic acid based mass spectrometry for DNA sequencing and microbial analysis at Sequenom, Inc. Dr. Honisch received her Ph.D. in molecular biology and microbiology from the University Carolo-Wilheimina zu Braunschweig, Germany and the German National Center for Biotechnology (GBF) in the field of the diagnosis and typing of tuberculosis. →

Thierry Laugel, PhD, MBA

Thierry Laugel, PhD, MBA

Dr. Thierry Laugel, Ph.D. is a co-Founder and Managing Partner at Kurma Partners since 2009. He was previously Partner at AGF Private Equity, (2006 to 2009) and CDC Innovation (1998 to 2005). Before that, he worked for Flamel Technologies as Project Director for Pharmaceutical R&D (1997-1998) and Fournier Japan, as Coordinator of R&D programmes (1992 – 1996). He has served as Director or Board member in more than 20 companies. Dr. Laugel holds a Pharm.D, a Ph.D. in Pharmacology, and an M.B.A. from INSEAD. →

Jean-Pascal Beaufret

Jean-Pascal Beaufret

Mr. Beaufret is the Chief Financial Officer of NBN Co. Limited. He also served as a General Manager of Electrobanqueand. He was Executive in the Ministry of Finance, Deputy Secretary of the international department from 1986 to 1988 and, Deputy Secretary for monetary affairs from 1988 to 1994. He served as General Manager of the French tax administration office since 1997. Mr. Beaufret serves as a Member of the Advisory Board at Aurinvest. He has been Vice Chairman at Sequana S.A., since June 27, 2013, and has been its Independent Director since May 21, 2008. He served as Member of the Supervisory Board at Portigon AG since August 1, 2002. He is a graduate of HEC (Paris Business School) and of the ENA (French National School of Public Administration). →

w

Let’s Start Something New

Welcome to PathoQuest!